Macquarie Group
SMMT icon

Macquarie Group’s Summit Therapeutics SMMT Stock Holding History

Macquarie Group’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,705
Closed -$143K – 1694
2025
Q2 		$143K Sell
6,705
-103,008
-94% -$2.35M ﹤0.01% 1558
2025
Q1 		$2.12M Buy
109,713
+23,960
+28% +$481K ﹤0.01% 1203
2024
Q4 		$1.53M Buy
+85,753
New +$1.66M ﹤0.01% 1270
2024
Q3 		– Sell
-1,274
Closed -$9.94K – 1879
2024
Q2 		$9.94K Buy
+1,274
New +$6.88K ﹤0.01% 1659

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
ACL
APEIRON Capital Ltd Hong Kong $107M AUM 9.59% 1-Year Est. Return